News about Biotechnology

Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites

Piramal Pharma Solutions has successfully developed and commercialised a tablet-in-capsule drug delivery system in India, enabling flexible dosing, dual-release profiles and improved patient-centric oral therapies.

Biotechnology | 03/02/2026 | By News Bureau |  264

USA Biomanufacturing Investment Surges Nearly 20 Percent, Report Finds

Investment in biomanufacturing across the USA has recorded a sharp rise, with pledged capital increasing by nearly 20 percent since 2024, according to a recent industry report. The surge positions biomanufacturing as one of the fastest-growing segments within the country’s advanced manufacturing landscape.
<br />

Biotechnology | 31/01/2026 | By Darshana |  248

Defence Therapeutics Advances Precision Radiopharmaceutical Development with CNL

Defence Therapeutics Inc., a publicly traded biotechnology company focused on precision intracellular drug delivery, has announced an expansion of its long-standing collaboration with Canadian Nuclear Laboratories (CNL) to accelerate the development of its radiopharmaceutical pipeline.

Biotechnology | 30/01/2026 | By Darshana |  149

Lilly Bets Big on Precision Immunology in USD 1.93 Billion Partnership

Eli Lilly and Company has entered into a strategic collaboration with biotechnology firm Repertoire Immune Medicines in a deal valued at up to USD 1.93 billion to develop novel therapies for autoimmune diseases.

Biotechnology | 30/01/2026 | By Darshana |  191

FDA Grants Breakthrough Therapy Designation to Biogen's Litifilimab for Cutaneous Lupus

Biogen’s investigational monoclonal antibody litifilimab receives FDA Breakthrough Therapy designation, marking a major step toward targeted treatment for cutaneous lupus erythematosus.

Biotechnology | 29/01/2026 | By News Bureau |  218

GSK to Acquire RAPT Therapeutics for USD 2.2 Billion to Strengthen Food Allergy and Immunology Pipeline

GSK will acquire RAPT Therapeutics for USD 2.2 billion, adding phase IIb anti-IgE antibody ozureprubart to its pipeline, targeting long-acting protection for patients with severe food allergies.

Biotechnology | 20/01/2026 | By News Bureau |  258

Onyx Scientific Strengthens Solid Form Screening Platform Following 25-Year Milestone

Onyx Scientific, the contract development and manufacturing organisation (CDMO) division of Ipca Laboratories, has announced plans to expand its solid form and material science screening capabilities in 2026, following the celebration of its 25th anniversary at the end of 2025.

Biotechnology | 20/01/2026 | By Darshana |  276

European Commission Approves Sobi's Aspaveli for Rare Kidney Diseases C3G and IC-MPGN

The European Commission has approved Sobi’s Aspaveli for adolescents and adults with rare kidney diseases C3G and IC-MPGN, marking the first approved therapy for these conditions.

Biotechnology | 19/01/2026 | By News Bureau |  273

IDT- Ansa Alliance Brings High-Complexity, Long-Length DNA Synthesis to Global Researchers

Integrated DNA Technologies (IDT), a Danaher company and a global genomics solutions provider, has entered into a strategic collaboration with Ansa Biotechnologies Inc to enhance its synthetic biology portfolio with advanced DNA synthesis capabilities.

Biotechnology | 17/01/2026 | By Darshana |  322

BD Secures FDA 510(k) Clearance for EnCor EnCompass Multi-Modality Breast Biopsy System

BD has received FDA 510(k) clearance for its EnCor EnCompass multi-modality breast biopsy system, designed to improve procedural efficiency, clinician flexibility and early detection and diagnosis of breast disease.

Biotechnology | 17/01/2026 | By News Bureau |  227